Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-07-12 12:07 pm Purchase | 13G | ATYR PHARMA INC LIFE | FMR LLC | 1,675,880 10.432% | 91,196 (+5.75%) | View |
| 2021-04-12 1:05 pm Purchase | 13G | ATYR PHARMA INC LIFE | FMR LLC | 1,584,684 9.897% | 56,866 (+3.72%) | View |
| 2021-04-09 2:14 pm Unchanged | 13G | ATYR PHARMA INC LIFE | FEDERATED HERMES INC. FHI | 1,615,000 10.09% | 0 (Unchanged) | View |
| 2021-02-17 06:10 am Purchase | 13G | ATYR PHARMA INC LIFE | Aspire Capital Fund LLC | 1,312,537 9.15% | 1,312,537 (New Position) | View |
| 2021-02-16 11:21 am Purchase | 13G | ATYR PHARMA INC LIFE | Alyeska Investment Group L.P. | 842,554 8.3% | 842,554 (New Position) | View |
| 2021-02-12 7:29 pm Sale | 13G | ATYR PHARMA INC LIFE | VIKING GLOBAL INVESTORS LP | 0 0% | -816,728 (Position Closed) | View |
| 2021-02-12 3:14 pm Sale | 13G | ATYR PHARMA INC LIFE | Altium Capital Management LP | 332,258 3.2% | -142,742 (-30.05%) | View |
| 2021-02-12 1:17 pm Purchase | 13G | ATYR PHARMA INC LIFE | FEDERATED HERMES INC. FHI | 1,615,000 15.86% | 1,019,928 (+171.40%) | View |
| 2021-02-10 6:20 pm Purchase | 13G | ATYR PHARMA INC LIFE | RENAISSANCE TECHNOLOGIES LLC | 319,130 3.13% | 119,210 (+59.63%) | View |
| 2021-02-08 10:15 am Purchase | 13G | ATYR PHARMA INC LIFE | FMR LLC | 1,527,818 14.999% | 1,036,369 (+210.88%) | View |
| 2021-01-21 5:48 pm Sale | 13G | ATYR PHARMA INC LIFE | Domain Partners VIII L.P. | 89,425 0.9% | -1,718,395 (-95.05%) | View |
| 2020-02-18 2:46 pm Purchase | 13G | ATYR PHARMA INC LIFE | Altium Capital Management LP | 475,000 5.8% | 475,000 (New Position) | View |
| 2020-02-14 1:29 pm Sale | 13G | ATYR PHARMA INC LIFE | FEDERATED HERMES INC. FHI | 595,072 15.3% | -6,798,643 (-91.95%) | View |
| 2020-02-14 10:34 am Purchase | 13D | ATYR PHARMA INC LIFE | SCHIMMEL PAUL | 509,982 5.97% | 509,982 (New Position) | View |
| 2020-02-12 2:41 pm Purchase | 13G | ATYR PHARMA INC LIFE | RENAISSANCE TECHNOLOGIES LLC | 199,920 5.14% | 199,920 (New Position) | View |
| 2020-02-11 1:27 pm Sale | 13G | ATYR PHARMA INC LIFE | VIKING GLOBAL INVESTORS LP | 816,728 9.4% | -2,189,572 (-72.83%) | View |
| 2020-02-07 11:12 am Purchase | 13G | ATYR PHARMA INC LIFE | FMR LLC | 491,449 12.633% | 491,449 (New Position) | View |
| 2020-01-14 5:28 pm Sale | 13G | ATYR PHARMA INC LIFE | Alta Partners VIII L.P. | 0 0% | -1,590,920 (Position Closed) | View |
| 2019-07-17 4:44 pm Sale | 13D | ATYR PHARMA INC LIFE | Polaris Venture Partners V L.P. | 130,571 3.7% | -21,697,421 (-99.40%) | View |
| 2019-07-10 2:58 pm Purchase | 13G | ATYR PHARMA INC LIFE | FMR LLC | 6,880,252 14.999% | 2,698,314 (+64.52%) | View |